Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs
  2. Silver, K I; Patkar, S; Mazcko, C; Berger,Erika; Beck, J A; LeBlanc, A K
  3. Veterinary and Comparative Oncology. 2023, Aug 17;
  1. 2.   Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft Model
  2. Huang, Shan; Ren, Ling; Beck, Jessica A; Phelps, Tim E; Olkowski, Colleen; Ton, Anita; Roy, Jyoti; White, Margaret E; Adler,Stephen; Wong, Karen; Cherukuri, Aswini; Zhang, Xiang; Basuli, Falguni; Choyke, Peter L; Jagoda, Elaine M; LeBlanc, Amy K
  3. Cancer Biotherapy & Radiopharmaceuticals. 2023, May 29;
  1. 3.   ERK phosphorylation is dependent on cell adhesion in a subset of pediatric sarcoma cell lines
  2. Yoon, Hye-Young; Maron, Ben Y; Girald-Berlingeri, Sofia; Gasilina, Anjelika; Gollin, Josephine C; Jian, Xiaoying; Akpan, Itoro; Yohe,Marielle; Randazzo, Paul A; Chen, Pei-Wen
  3. Biochimica et Biophysica Acta. Molecular Cell Research. 2022, Apr 03; 1869(8):
  1. 4.   Identification of Potential Modulators of Osteosarcoma Metastasis by High Throughput Cellular Screening of Natural Products
  2. Long, Sarah A; Huang, Shan; Kambala, Anusha; Ren, Ling; Wilson,Jennifer; Goetz, Michael; Hao, Xiaojiang; Yang, Xiaosheng; Goncharova,Katya; Jia, Libin; LeBlanc, Amy; Khanna, Chand; Henrich,Curtis; Beutler,John
  3. Chemical biology & drug design. 2020, JUL 28;
  1. 5.   PPAR gamma Agonist Pioglitazone in Combination With Cisplatinum Arrests a Chemotherapy-resistant Osteosarcoma PDOX Model
  2. Higuchi, Takashi; Yamamoto, Jun; Sugisawa, Norihiko; Tashiro, Yoshihiko; Nishino, Hiroto; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Bouvet, Michael; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Cancer genomics & proteomics. 2020, Jan-Feb; 17(1): 35-40.
  1. 6.   A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Igarashi, Kentaro; Kawaguchi, Kei; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Higuchi, Takashi; Taniguchi, Yuta; Yonezawa, Hirotaka; Araki, Yoshihiro; Morinaga, Sei; Misra,Sweta; Nelson, Scott D.; Dry, Sarah M.; Li, Yunfeng; Odani, Akira; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M.
  3. Cancer genomics & proteomics. 2020, May-Jun; 17(3): 217-223.
  1. 7.   The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model
  2. Higuchi, Takashi; Sugisawa, Norihiko; Yamamoto, Jun; Oshiro, Hiromichi; Han, Qinghong; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Tan, Yuying; Kuchipudi, Shreya; Bouvet, Michael; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Cancer chemotherapy and pharmacology. 2019, Nov 08;
  1. 8.   Pioglitazone, an agonist of PPAR?, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression
  2. Higuchi, Takashi; Sugisawa, Norihiko; Miyake, Kentaro; Oshiro, Hiromichi; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Kline,Zoey; Bouvet, Michael; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2019, Oct; 118: 109356.
  1. 9.   Oral Recombinant Methioninase, Combined With Oral Caffeine and Injected Cisplatinum, Overcome Cisplatinum-Resistance and Regresses Patient-derived Orthotopic Xenograft Model of Osteosarcoma
  2. Higuchi, Takashi; Oshiro, Hiromichi; Miyake, Kentaro; Sugisawa, Norihiko; Han, Qinghong; Tan, Yuying; Park, Junho; Zhang, Zhiying; Razmjooei, Sahar; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Bouvet, Michael; Chawla, Sant P; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Anticancer research. 2019, Sep; 39(9): 4653-4657.
  1. 10.   Eribulin Suppressed Cisplatinum- and Doxorubicin-resistant Recurrent Lung Metastatic Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
  2. Kiyuna, Tasuku; Tome, Yasunori; Miyake, Kentaro; Murakami, Takashi; Oshiro, Hiromichi; Igarashi, Kentaro; Kawaguchi, Kei; Hsu, John; Singh, Manish; Li, Yunfeng; Nelson, Scott; Bouvet, Michael; Singh,Shree Ram; Kanaya, Fuminori; Hoffman, Robert M
  3. Anticancer research. 2019, Sep; 39(9): 4775-4779.
  1. 11.   Combination Treatment With Sorafenib and Everolimus Regresses a Doxorubicin-resistant Osteosarcoma in a PDOX Mouse Model
  2. Higuchi, Takashi; Sugisawa, Norihiko; Miyake, Kentaro; Oshiro, Hiromichi; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Kline,Zoey; Belt,Paige; Chawla, Sant P; Bouvet, Michael; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Anticancer research. 2019, Sep; 39(9): 4781-4786.
  1. 12.   Sorafenib and Palbociclib Combination Regresses a Cisplatinum-resistant Osteosarcoma in a PDOX Mouse Model
  2. Higuchi, Takashi; Sugisawa, Norihiko; Miyake, Kentaro; Oshiro, Hiromichi; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Chawla, Sant P; Bouvet, Michael; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M
  3. Anticancer research. 2019, Aug; 39(8): 4079-4084.
  1. 13.   Trabectedin and irinotecan combination regresses a cisplatinum-resistant osteosarcoma in a patient-derived orthotopic xenograft nude-mouse model
  2. Higuchi, Takashi; Miyake, Kentaro; Oshiro, Hiromichi; Sugisawa, Norihiko; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Miwa, Shinji; Igarashi, Kentaro; Chawla, Sant P.; Bouvet, Michael; Singh,Shree Ram; Tsuchiya, Hiroyuki; Hoffman, Robert M.
  3. Biochemical and biophysical research communications. 2019, MAY 28; 513(2): 326-331.
  1. 14.   CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
  2. Majzner, Robbie G.; Theruvath, Johanna L.; Nellan, Anandani; Heitzeneder, Sabine; Cui, Yongzhi; Mount, Christopher W.; Rietberg, Skyler P.; Linde, Miles H.; Xu, Peng; Rota, Christopher; Sotillo, Elena; Labanieh, Louai; Lee, Daniel W.; Orentas, Rimas J.; Dimitrov, Dimiter S.; Zhu, Zhongyu; St Croix,Brad; Delaidelli, Alberto; Sekunova, Alla; Bonvini, Ezio; Mitra, Siddhartha S.; Quezado, Martha M.; Majeti, Ravindra; Monje, Michelle; Sorensen, Poul H. B.; Maris, John M.; Mackall, Crystal L.
  3. CLINICAL CANCER RESEARCH. 2019, APR 15; 25(8): 2560-2574.
  1. 15.   Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients
  2. Koster, Roelof; Panagiotou, Orestis A; Wheeler, William A; Karlins, Eric; Gastier-Foster, Julie M; Caminada de Toledo, Silvia Regina; Petrilli, Antonio S; Flanagan, Adrienne M; Tirabosco, Roberto; Andrulis, Irene L; Wunder, Jay S; Gokgoz, Nalan; Patiño-Garcia, Ana; Lecanda, Fernando; Serra, Massimo; Hattinger, Claudia; Picci, Piero; Scotlandi, Katia; Thomas, David M; Ballinger, Mandy L; Gorlick, Richard; Barkauskas, Donald A; Spector, Logan G; Tucker, Margaret; Hicks, Belynda; Yeager, Meredith; Hoover, Robert N; Wacholder, Sholom; Chanock, Stephen J; Savage, Sharon A; Mirabello, Lisa
  3. International journal of cancer. 2018, Apr 15; 142(8): 1594-1601.
  1. 16.   Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells
  2. Bulut, G.; Hong, S. H.; Chen, K.; Beauchamp, E. M.; Rahim, S.; Kosturko, G. W.; Glasgow, E.; Dakshanamurthy, S.; Lee, H. S.; Daar, I.; Toretsky, J. A.; Khanna, C.; Uren, A.
  3. Oncogene. 2012, Jan; 31(3): 269-281.
  1. 17.   Hypoxia, stem cells and bone tumor
  2. Zeng, W.; Wan, R.; Zheng, Y. H.; Singh, S. R.; Wei, Y. Y.
  3. Cancer Letters. 2011, Dec; 313(2): 129-136.
  1. 18.   Protein kinase C regulates ezrin-radixin-moesin phosphorylation in canine osteosarcoma cells
  2. Hong, S. H.; Osborne, T.; Ren, L.; Briggs, J.; Mazcko, C.; Burkett, S. S.; Khanna, C.
  3. Veterinary and Comparative Oncology. 2011, Sep; 9(3): 207-218.
  1. 19.   Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells
  2. Ohta, S.; Lai, E. W.; Morris, J. C.; Pang, A.; Watanabe, M.; Yazawa, H.; Zhang, R.; Green, J. E.; Chan, W. Y.; Sirajuddin, P.; Taniguchi, S.; Powers, J. F.; Tischler, A. S.; Pacak, K.
  3. Molecular Carcinogenesis. 2008 47(4): 245-251.
  1. 20.   The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1
  2. Li, B. Q.; Wetzel, M. A.; Mikovits, J. A.; Henderson, E. E.; Rogers, T. J.; Gong, W.; Le, Y.; Ruscetti, F. W.; Wang, J. M.
  3. Blood. 2001 97(10): 2941-2947.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel